Table Filtering
Other Information
Release Statistics Download
GlyCosmos Glycolipids

Glycolipid entries from the LIPID MAPS Structure Database (LMSD).

Source Last Updated
LIPID MAPS Proteome Database (LMSD) June 16, 2024
Displaying entries 1301 - 1325 of 3913 in total
Main Class Sub Class LM ID Name LipidBank ID KEGG ID PubChem CID ChEBI ID Exact Mass Formula ▲
Neutral glycosphingolipids Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) LMSP0504AA06
  • GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/26:0)
  • Lc3Cer(d18:1/26:0)
44260617 1204.853618 C64H120N2O18
Neutral glycosphingolipids GlcNAcbeta1-4Manbeta1-4Glc- (Arthro series) LMSP0508AA06
  • GlcNAcbeta1-4Manbeta1-4Glcbeta-Cer(d18:1/26:0)
44261953 1204.853618 C64H120N2O18
Acidic glycosphingolipids Gangliosides LMSP0601AM01
  • GM2(d18:1/16:0)
  • GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/16:0)
44262060 141459 1355.792537 C65H117N3O26
Acidic glycosphingolipids Gangliosides LMSP0601EK01
  • NeuAcalpha2-6GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/16:0)
44262828 1355.792537 C65H117N3O26
Acidic glycosphingolipids Gangliosides LMSP0601CI01
  • GalNAcbeta1-4(NeuGcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/16:0)
52931289 1371.787452 C65H117N3O27
Acidic glycosphingolipids Gangliosides LMSP0601AJ07
  • GM3(d18:1/24:1(15Z))
  • NeuAcalpha2-3Galbeta1-4Glcbeta-Cer(d18:1/24:1(15Z))
44262042 84989 1262.822713 C65H118N2O21
Acidic glycosphingolipids Gangliosides LMSP0601DC02
  • Galbeta1-4(NeuAcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/18:0)
44262573 1342.797288 C65H118N2O26
Acidic glycosphingolipids Gangliosides LMSP0601DG02
  • GalNAcbeta1-4(KDNalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/18:0)
  • KDN-GM2(d18:1/18:0)
44262605 1342.797288 C65H118N2O26
Acidic glycosphingolipids Gangliosides LMSP0601DH08
  • KDNalpha2-3Galbeta1-4Glcbeta-Cer(d18:1/26:1(17Z))
44262619 1249.827464 C65H119NO21
Acidic glycosphingolipids Gangliosides LMSP0601AJ05
  • GM3(d18:1/24:0)
  • NeuAcalpha2-3Galbeta1-4Glcbeta-Cer(d18:1/24:0)
44262040 84681 1264.838363 C65H120N2O21
Acidic glycosphingolipids Gangliosides LMSP0601DH06
  • KDNalpha2-3Galbeta1-4Glcbeta-Cer(d18:1/26:0)
44262617 1251.843114 C65H121NO21
Neutral glycosphingolipids GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) LMSP0503AI01
  • Fucalpha1-2Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/16:0)
44260548 1372.807853 C66H120N2O27
Neutral glycosphingolipids Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) LMSP0504AC01
  • Galbeta1-3(Fucalpha1-4)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0)
  • Lewis a(d18:1/16:0)
44260628 1372.807853 C66H120N2O27
Neutral glycosphingolipids Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) LMSP0504AD01
  • Fucalpha1-2Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0)
  • type I H antigen(d18:1/16:0)
44260636 1372.807853 C66H120N2O27
Neutral glycosphingolipids Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) LMSP0505AB01
  • Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0)
  • Lex-5(d18:1/16:0)
44260980 1372.807853 C66H120N2O27
Neutral glycosphingolipids Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) LMSP0505AD01
  • Fucalpha1-2Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0)
  • type II antigen(d18:1/16:0)
44260996 1372.807853 C66H120N2O27
Neutral glycosphingolipids Galalpha1-3Galbeta1-4Glc- (Isoglobo series) LMSP0506AV01
  • Fucalpha1-3GlcNAcbeta1-3Galalpha1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0)
44261604 1372.807853 C66H120N2O27
Neutral glycosphingolipids Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502AE01
  • Galbeta1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/16:0)
  • SSEA-3 antigen(d18:1/16:0)
44260196 1388.802768 C66H120N2O28
Neutral glycosphingolipids Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502AP01
  • GalNAcbeta1-3Galalpha1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/16:0)
44260284 1388.802768 C66H120N2O28
Neutral glycosphingolipids Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502BA01
  • Galalpha1-4GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/16:0)
44260372 1388.802768 C66H120N2O28
Neutral glycosphingolipids Galalpha1-4Galbeta1-4Glc- (Globo series) LMSP0502BK01
  • Galbeta1-3GalNAcbeta1-4Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/16:0)
44260452 1388.802768 C66H120N2O28
Neutral glycosphingolipids GalNAcbeta1-4Galbeta1-4Glc- (Ganglio series) LMSP0503AJ01
  • Galalpha1-3Galbeta1-3GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/16:0)
44260556 1388.802768 C66H120N2O28
Neutral glycosphingolipids Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) LMSP0504AQ01
  • Galbeta1-3Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0)
44260740 1388.802768 C66H120N2O28
Neutral glycosphingolipids Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) LMSP0504BU01
  • Galalpha1-3Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0)
44260964 1388.802768 C66H120N2O28
Neutral glycosphingolipids Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series) LMSP0505AC01
  • Galalpha1-3Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/16:0)
44260988 1388.802768 C66H120N2O28

About Release Notes Help Feedback

Click here to visit the beta site.


International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.0.0

Last updated: August 19, 2024